Bristol Myers Squibb
Organization
Bristol Myers Squibb is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. It is one of the world's largest pharmaceutical companies, specializing in the discovery, development, and delivery of innovative medicines for serious diseases such as cancer, cardiovascular conditions, and immunological disorders.
What experts have said about Bristol Myers Squibb
1 statement · 1 positive
Bristol Myers Squibb reported its highest-ever quarterly sales.
“Bristol Mayors last week reported its highest ever quarterly sales”
Open the episode · AstraZeneca Plummets, Ryanair Rises, Clarkson JumpsListen at 1:33
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
5 episodes featuring Bristol Myers Squibb

Stock Movers
Tyson Foods lowers outlook while AstraZeneca eyes Bristol Myers Squibb merger
Major market shifts are colliding as agricultural inflation squeezes food production, biotech giants pursue massive consolidation, and aerospace enters a new public era.
Aug 3, 2026 · 7 min

Stock Movers
AstraZeneca weighs historic merger while chip stocks stage a recovery
This episode provides critical analysis of landmark shifts in global markets, from historic healthcare consolidation to the financial debut of commercial space flight.
Aug 3, 2026 · 6 min

Stock Movers
AstraZeneca plunges and BP divests as European markets undergo major shakeups
Understanding these major corporate realignments reveals how strategic shifts and geopolitical tensions are reshaping key European business sectors.
Aug 3, 2026 · 7 min

Stock Movers
AstraZeneca drops on merger talks while airlines and shipping surge
This episode highlights how shifting energy costs, geopolitical shipping disruptions, and aggressive cross-border healthcare deals are rapidly reshaping European equity markets.
Aug 3, 2026 · 7 min

The Sunday Roast
Biotech promise meets copper development risk
The episode contrasts Coiled Therapeutics’ clinical ambitions with Halo Minerals’ path from permitted project to copper production and expansion.
May 10, 2026 · 1h 9m
